Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.1.1.21 extracted from

  • Maccari, R.; Ottana, R.; Curinga, C.; Vigorita, M.G.; Rakowitz, D.; Steindl, T.; Langer, T.
    Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors (2005), Bioorg. Med. Chem., 13, 2809-2823.
    View publication on PubMed
Search for more literature for 1.1.1.21

Inhibitors

Inhibitors Comment Organism Structure
(5-biphenyl-4-ylmethylene-2,4-dioxothiazolidin-3-yl)-acetic acid IC50: 0.00026 mM Bos taurus
(5-biphenyl-4-ylmethylene-2,4-dioxothiazolidin-3-yl)-acetic acid methyl ester 35% inhibition of ALR2 at 0.05 mM Bos taurus
(5-naphthalen-1-ylmethylene-2,4-dioxothiazolidin-3-yl)acetic acid IC50: 0.00017 mM Bos taurus
(5-naphthalen-1-ylmethylene-2,4-dioxothiazolidin-3-yl)acetic acid methyl ester 12% inhibition of ALR2 at 0.05 mM Bos taurus
4-(5-biphenyl-4-ylmethylene-2,4-dioxothiazolidin-3-yl)-2-butenoic acid 21% inhibition of ALR2 at 0.05 mM Bos taurus
4-(5-biphenyl-4-ylmethylene-2,4-dioxothiazolidin-3-yl)-2-butenoic acid methyl ester 6% inhibition of ALR2 at 0.05 mM Bos taurus
4-[2,4-dioxo-5-(3-phenoxybenzylidene)thiazolidin-3-yl]-2-butenoic acid 19% inhibition of ALR2 at 0.05 mM Bos taurus
4-[2,4-dioxo-5-(3-phenoxybenzylidene)thiazolidin-3-yl]-2-butenoic acid methyl ester 25% inhibition of ALR2 at 0.05 mM Bos taurus
4-[2,4-dioxo-5-(4-phenoxybenzylidene)thiazolidin-3-yl]-2-butenoic acid 57% inhibition of ALR2 at 0.05 mM Bos taurus
4-[5-(4-benzyloxybenzylidene)-2,4-dioxothiazolidin-3-yl]-2-butenoic acid methyl ester 23% inhibition of ALR2 at 0.05 mM Bos taurus
4-[5-(4-hydroxybenzylidene)-2,4-dioxothiazolidin-3-yl]-2-butenoic acid IC50: 0.0042 mM Bos taurus
5-(3-aminobenzylidene)-2,4-thiazolidinedione IC50: 0.0202 mM Bos taurus
5-(3-hydroxybenzylidene)-2,4-thiazolidinedione IC50: 0.0107 mM Bos taurus
5-(3-nitrobenzylidene)-2,4-thiazolidinedione 21% inhibition of ALR2 at 0.05 mM Bos taurus
5-(4-aminobenzylidene)-2,4-thiazolidinedione 44% inhibition of ALR2 at 0.05 mM Bos taurus
5-(4-benzyloxybenzylidene)-2,4-thiazolidinedione 10% inhibition of ALR2 at 0.05 mM Bos taurus
5-(4-hydroxybenzylidene)-2,4-thiazolidinedione IC50: 0.009 mM Bos taurus
5-(4-nitrobenzylidene)-2,4-thiazolidinedione 37% inhibition of ALR2 at 0.05 mM Bos taurus
5-biphenyl-4-ylmethylene-2,4-thiazolidinedione 20% inhibition of ALR2 at 0.05 mM Bos taurus
5-naphthalen-1-ylmethylene-2,4-thiazolidinedione IC50: 0.0107 mM Bos taurus
epalrestat
-
 Bos taurus
additional information molecular modelling, enzyme docking at the active site of the enzyme, structure-activity relationships of 5-arylidene-2,4-thiazolidinediones, an additional aromatic ring or an H-bond donor group on the 5-benzylidene ring enhance ALR2 inhibitory potency, the presence of a carboxylic anionic chain on N-3 is important, and the length of the carboxylic chain is critical, overview, no inhibition by 5b 4-[2,4-dioxo-5-(4-phenoxybenzylidene)thiazolidin-3-yl]-2-butenoic acid methyl ester Bos taurus
ponalrestat IC50: 80 nM Bos taurus
sorbinil IC50: 0.0011 mM Bos taurus
zopolrestat
-
 Bos taurus
[2,4-dioxo-5-(4-phenoxybenzylidene)thiazolidin-3-yl]acetic acid IC50: 0.00082 mM Bos taurus
[2,4-dioxo-5-(4-phenoxybenzylidene)thiazolidin-3-yl]acetic acid methyl ester 33% inhibition of ALR2 at 0.05 mM Bos taurus
[5-(3-aminobenzylidene)-2,4-dioxothiazolidin-3-yl]-acetic acid methyl ester IC50: 0.039 mM Bos taurus
[5-(3-hydroxybenzylidene)-2,4-dioxothiazolidin-3-yl]acetic acid IC50: 0.00066 mM Bos taurus
[5-(3-hydroxybenzylidene)-2,4-dioxothiazolidin-3-yl]acetic acid methyl ester 43% inhibition of ALR2 at 0.05 mM Bos taurus
[5-(3-nitrobenzylidene)-2,4-dioxothiazolidin-3-yl]-acetic acid IC50: 0.00049 mM Bos taurus
[5-(3-nitrobenzylidene)-2,4-dioxothiazolidin-3-yl]-acetic acid methyl ester 22% inhibition of ALR2 at 0.05 mM Bos taurus
[5-(4-aminobenzylidene)-2,4-dioxothiazolidin-3-yl]-acetic acid methyl ester 25% inhibition of ALR2 at 0.05 mM Bos taurus
[5-(4-benzyloxybenzylidene)-2,4-dioxothiazolidin-3-yl]acetic acid IC50: 0.00028 mM Bos taurus
[5-(4-benzyloxybenzylidene)-2,4-dioxothiazolidin-3-yl]acetic acid methyl ester 12% inhibition of ALR2 at 0.05 mM Bos taurus
[5-(4-hydroxybenzylidene)-2,4-dioxothiazolidin-3-yl]acetic acid IC50: 0.00015 mM Bos taurus
[5-(4-hydroxybenzylidene)-2,4-dioxothiazolidin-3-yl]acetic acid methyl ester IC50: 0.0062 mM Bos taurus
[5-(4-nitrobenzylidene)-2,4-dioxothiazolidin-3-yl]-acetic acid IC50: 0.0012 mM Bos taurus
[5-(4-nitrobenzylidene)-2,4-dioxothiazolidin-3-yl]-acetic acid methyl ester 8% inhibition of ALR2 at 0.05 mM Bos taurus

Organism

Organism UniProt Comment Textmining
Bos taurus
-
-
-

Purification (Commentary)

Purification (Comment) Organism
native enzyme from lens by anion exchange chromatography Bos taurus

Source Tissue

Source Tissue Comment Organism Textmining
lens
-
 Bos taurus
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
glyceraldehyde + NADPH + H+
-
 Bos taurus glycerol + NADP+
-
 ?

Synonyms

Synonyms Comment Organism
aldose reductase
-
 Bos taurus
ALR2
-
 Bos taurus

Temperature Optimum [°C]

Temperature Optimum [°C] Temperature Optimum Maximum [°C] Comment Organism
37
-
 assay at Bos taurus

pH Optimum

pH Optimum Minimum pH Optimum Maximum Comment Organism
6.8
-
 assay at Bos taurus

Cofactor

Cofactor Comment Organism Structure
NADPH
-
 Bos taurus

IC50 Value

IC50 Value IC50 Value Maximum Comment Organism Inhibitor Structure
0.00008
-
 IC50: 80 nM Bos taurus ponalrestat
0.00015
-
 IC50: 0.00015 mM Bos taurus [5-(4-hydroxybenzylidene)-2,4-dioxothiazolidin-3-yl]acetic acid
0.00017
-
 IC50: 0.00017 mM Bos taurus (5-naphthalen-1-ylmethylene-2,4-dioxothiazolidin-3-yl)acetic acid
0.00026
-
 IC50: 0.00026 mM Bos taurus (5-biphenyl-4-ylmethylene-2,4-dioxothiazolidin-3-yl)-acetic acid
0.00028
-
 IC50: 0.00028 mM Bos taurus [5-(4-benzyloxybenzylidene)-2,4-dioxothiazolidin-3-yl]acetic acid
0.00049
-
 IC50: 0.00049 mM Bos taurus [5-(3-nitrobenzylidene)-2,4-dioxothiazolidin-3-yl]-acetic acid
0.00066
-
 IC50: 0.00066 mM Bos taurus [5-(3-hydroxybenzylidene)-2,4-dioxothiazolidin-3-yl]acetic acid
0.00082
-
 IC50: 0.00082 mM Bos taurus [2,4-dioxo-5-(4-phenoxybenzylidene)thiazolidin-3-yl]acetic acid
0.0011
-
 IC50: 0.0011 mM Bos taurus sorbinil
0.0012
-
 IC50: 0.0012 mM Bos taurus [5-(4-nitrobenzylidene)-2,4-dioxothiazolidin-3-yl]-acetic acid
0.0042
-
 IC50: 0.0042 mM Bos taurus 4-[5-(4-hydroxybenzylidene)-2,4-dioxothiazolidin-3-yl]-2-butenoic acid
0.0062
-
 IC50: 0.0062 mM Bos taurus [5-(4-hydroxybenzylidene)-2,4-dioxothiazolidin-3-yl]acetic acid methyl ester
0.009
-
 IC50: 0.009 mM Bos taurus 5-(4-hydroxybenzylidene)-2,4-thiazolidinedione
0.0107
-
 IC50: 0.0107 mM Bos taurus 5-naphthalen-1-ylmethylene-2,4-thiazolidinedione
0.0107
-
 IC50: 0.0107 mM Bos taurus 5-(3-hydroxybenzylidene)-2,4-thiazolidinedione
0.0202
-
 IC50: 0.0202 mM Bos taurus 5-(3-aminobenzylidene)-2,4-thiazolidinedione
0.039
-
 IC50: 0.039 mM Bos taurus [5-(3-aminobenzylidene)-2,4-dioxothiazolidin-3-yl]-acetic acid methyl ester